@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-GP5BCVND-L
  skos:prefLabel "Flavones"@fr, "Flavones"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-Z07G030T-S .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-Z07G030T-S
  mesh:allowableQualifier jvr:-NKM836P1-M, jvr:-W6SQV79N-S, jvr:-NB0XHT3S-N, jvr:-THHNVC7V-3, jvr:-XV06LPML-W, jvr:-R3QWLHRG-V, jvr:-TJHVZCRZ-0, jvr:-G4R176S9-J, jvr:-NFTHND7Q-8, jvr:-SBNWSM1T-R, jvr:-L6C0XPHT-4, jvr:-FWD2BGQ0-9, jvr:-BT300B3G-Q, jvr:-WK5F724J-1, jvr:-HQRFT0C6-B, jvr:-M63HSDM7-1, jvr:-R0ZCQ8X6-J, jvr:-S0CS1X5R-5, jvr:-H7K65Q8S-Z, jvr:-Q3979798-W, jvr:-T9HQD7ST-J, jvr:-D0F21513-5, jvr:-NHL3D2X0-S, jvr:-CB30NGKB-3, jvr:-G30ZJ446-J ;
  skos:hiddenLabel "Flavoxate Hydrochloride"@en, "Chlorhydrate de flavoxate"@fr, "Bladuril"@en, "Uronid"@en, "Spasuret"@en, "Urispas"@en ;
  dc:established "1991-01-01"^^xsd:date ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D005422> ;
  dc:modified "2017-05-24"^^xsd:date ;
  skos:broader jvr:-GP5BCVND-L ;
  mesh:pharmacologicalAction jvr:-TW1NK90Q-W, jvr:-JPNMVWPP-P ;
  skos:inScheme jvr: ;
  a skos:Concept, mesh:Descriptor ;
  skos:altLabel "9C05J6089W"@fr, "9C05J6089W"@en, "15301-69-6 (Flavoxate)"@en, "15301-69-6 (Flavoxate)"@fr, "3717-88-2 (Flavoxate Hydrochloride)"@fr, "3717-88-2 (Flavoxate Hydrochloride)"@en, "4H-1-Benzopyran-8-carboxylic acid, 3-methyl-4-oxo-2-phenyl-, 2-(1-piperidinyl)ethyl ester"@fr, "4H-1-Benzopyran-8-carboxylic acid, 3-methyl-4-oxo-2-phenyl-, 2-(1-piperidinyl)ethyl ester"@en, "3E74Y80MEY"@fr, "3E74Y80MEY"@en ;
  skos:definition "A drug that has been used in various urinary syndromes and as an antispasmodic. Its therapeutic usefulness and its mechanism of action are not clear. It may have local anesthetic activity and direct relaxing effects on smooth muscle as well as some activity as a muscarinic antagonist."@en ;
  dc:created "1976-04-13"^^xsd:date ;
  skos:prefLabel "Flavoxate"@en, "Flavoxate"@fr .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TW1NK90Q-W
  skos:prefLabel "Parasympatholytiques"@fr, "Parasympatholytics"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-JPNMVWPP-P
  skos:prefLabel "Urological Agents"@en, "Agents urologiques"@fr ;
  a mesh:Descriptor, skos:Concept .